Studying immune cells in children during surgery
Part of Immune system & allergy clinical trials.
This study looks closely at immune cells in children while they are having surgery under general anesthesia using a specific muscle-relaxing medicine (rocuronium). It may help researchers understand how immune systems respond around the time of surgery and anesthesia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 2 and 18 years old
- Your child will have surgery under general anesthesia
- The anesthesiology team will use the muscle relaxer rocuronium
- Your child has not recently taken medicines that change the immune system (immunomodulators or immunosuppressants)
- Your child does not have an autoimmune disease (like lupus, rheumatoid arthritis, or Behçet’s disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing how well a drug called sugammadex works at different doses to reverse the effects of muscle relaxants used during surgery in babies and children under 2 years old. It aims to find the safest and most effective dose for this age group.
This study looks at whether giving a deep muscle relaxant during your child's belly-button surgery can reduce pain after the operation. It may help kids feel better and recover more comfortably.
This study tests two devices that measure how well muscle relaxants work in young children during surgery. The goal is to see which device gives more accurate readings, helping doctors use the right dose of relaxant.
This study compares a new muscle relaxant medication with a standard one to see how well they work for placing a breathing tube and maintaining muscle relaxation during surgery. It aims to find a safer or more effective option for patients undergoing general anesthesia.
This trial tests a new drug called HRS-9190 against a standard muscle relaxant (cisatracurium) given continuously through an IV during surgery. It aims to see if the new drug works as well and is safe for adults having planned surgery under general anesthesia.
This trial compares two muscle relaxants, rocuronium and cisatracurium, to see which causes fewer complications in people with chronic kidney disease (not on dialysis) who need general anesthesia. If you have kidney disease and are having surgery that requires a breathing tube, this study may help determine the safer drug for you.
Hear when a new Drug Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.